# The European Investment Bank Group, the European Commission and the International Finance Corporation has announced a landmark financing partnership to support Biovac in building Africa’s first end-to-end multi-vaccine manufacturing facility in South Africa. Biovac CEO Morena Makhoana says the project is aimed at strengthening Africa’s health security, expanding vaccine manufacturing capacity on the continent and improving access to essential immunisations. He says the new facility would secure reliable vaccine supply for Africa while building skills, expanding technology transfer and driving vaccine innovation.
Africa’s first end-to-end multi-vaccine plant will be built in South Africa